Characterization of hepatic lymphocytes in patients with viral hepatitis and other liver diseases.

Characterization of hepatic lymphocytes in patients with viral hepatitis and other liver diseases. - Characterization of hepatic lymphocytes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47692

Enrollment

Registered

2012-01-12

Start date

2012-01-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis B chronic hepatitis C viral liverdisease

Interventions

Patients that are included in the study will donate 5 tubes of 9 ml blood once only 1-2 weeks before surgery.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients between 18-65 year old that undergo a liverresection.

Exclusion criteria

Exclusion criteria: Unwillingness to donate blood Co-infection with HIV (if known) (a HIV test is not required for participation in the study)

Design outcomes

Primary

Measure	Time frame
To phenotypically and functionally analyze liver and peripheral T cells in patients with viral hepatitis and other liver diseases in order to get more insight in immune system in the liver. Patients with viral hepatitis will be compared with patients with a non-viral liver related disease.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)